Retinol and retinoic acid dose-response curves were obtained for promotion of the differentiation of F9 murine embryonal carcinoma cells with an enzyme-linked immunoadsorbent assay for laminin, a product of differentiated F9 cells. Retinoic acid produced a half-maximum response at 1.3 ftM and a maximum response at about 30 nM; retinol was 1/175th as potent. Maximum differentiation required 48 hr of continuous exposure to retinoic acid, whereas retinol required 72 hr of exposure. The half-time of retinoic acid conversion into polar metabolites was 3.5 hr; metabolism was accelerated by pretreating F9 cells with retinoic acid. An inhibitor of oxidative metabolisms ketoconazole, decreased the rate of retinoic acid metabolism and decreased the concentration of retinoic acid required to produce a half-maximum response. Unchanged retinoic acid was the sole compound isolated from nuclei of F9 cells incubated with retinoic acid. Retinol had a half-life approximately 5-fold longer than retinoic acid, attained greater cell concentrations, and was converted into retinoic acid by F9 cells. These data indicate that retinoic acid itself directs the differentiation of F9 cells and may mediate differentiation induced by retinol.
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Retinol, the major plasma retinoid, supports all known vitamin A functions in vivo (1, 2) . Retinoic acid, a metabolite in the physiological pathway of retinol metabolism (3, 4) , supports growth and epithelial differentiation but does not support vision or reproduction in mammals (5) . Retinol and retinoic acid may function in part through two distinct cytoplasmic binding proteins (6, 7) : cellular retinol-binding protein, which specifically binds retinol; and cellular retinoic acid-binding protein, which specifically binds retinoic acid. Retinoids appear to have both nuclear (8, 9) and extranuclear mechanisms of action (10, 11) . The biochemical roles of retinoic acid relative to retinol are unclear, as is the function of retinoic acid metabolism.
Embryonal carcinoma (EC) cells are studied as models of differentiation (12) . Naturally occurring retinoids are the only physiological substances that induce differentiation of the murine EC cell line F9 (13, 14) . F9 cell responses to retinoic acid include decreased proliferation, loss of tumorigenicity, cell surface antigen changes, and alterations in protein synthesis. Retinoic acid-differentiated F9 cells secrete laminin, type IV collagen, and plasminogen activator, whereas these proteins are synthesized only at low levels, if at all, in undifferentiated cells (15, 16) . Retinoic acid treatment stimulates adenylate cyclase activity (17) and cAMP-dependent protein kinase activity (18) in F9 cells. EC cells are sensitized by retinoic acid to cAMP, which promotes their differentiation into parietal endoderm (15) . Thus, EC cells, with a homogeneous cell population and quantifiable biochemical markers of vitamin A action, provide a model system for investigating the structure/activity relationships of retinoids. This report will demonstrate that retinoic acid is 175-fold more potent than retinol in inducing F9 cell differentiation and that retinoic acid itself, rather than its metabolites, mediates differentiation. The response to retinol may be mediated by retinoic acid.
MATERIALS AND METHODS
Retinoids. Retinol and retinoic acid were purchased from Sigma. 5,6-Epoxyretinoic acid was synthesized (19) . [11,12-3H] Retinoic acid (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) Ci/mmol, 1 Ci = 37 GBq), 13-cisretinoic acid, and the all-trans-isomers of4-oxo-16-hydroxy-, 4-oxo-, and 4-hydroxyretinoic acid were gifts of Hoffmann-La Roche (Nutley, NJ).
[3H]Retinoic acid was purified by elution through a reversed-phase HPLC column with 10 mM ammonium acetate in methanol/water (7:3, vol/vol; elution volume 56 ml). [11-3H] Retinol (1.9 Ci/mmol) was prepared as described from [11-3H] retinal (20) , which was obtained from the Biological and Chemical Chemoprevention Program, Division of Cancer Cause and Prevention, National Cancer Institute. [11,12-3H] Retinol (43 Ci/mmol) was purchased from Amersham. Retinol was purified by elution through a normal-phase HPLC column with acetone/hexane (7: 93, vol/vol; elution volume 25 ml).
Cell Culture. F9 cells were obtained from Gail Martin (University of California, San Francisco) and were maintained in 2 ml of Dulbecco's modified Eagle's medium supplemented with 10% heat-inactivated fetal bovine serum (GIBCO), sodium pyruvate (1 mM), sodium bicarbonate (44 mM), penicillin (100 units/ml), streptomycin (100 ,ug/mi), and Fungizone (25 and each sample was extracted with hexane (2 ml). The hexane was removed under a stream of nitrogen and the residue was applied to a reversed-phase HPLC column.
[3H]Retinoic acid and 13-cis-[3H]retinoic acid were eluted from the column with 10 mM ammonium acetate in methanol/water (75:25, vol/vol) in 33 and 27 ml, respectively. The amount of total [3H]retinoic acid remaining was determined by measuring the radioactivity eluting with each isomer and correcting for recovery. Recovery was determined to be 80% from a standard curve relating the peak height of the radioinert retinoic acid to retinoic acid mass.
Quantification of Retinoic Acid Synthesis. Cells were harvested by gentle scraping and were suspended in 25-ml Erlenmeyer flasks in 2 ml of medium.
[3H]Retinol (43 Ci/mmol) was added; the flasks were purged with 02/CO2/N2 (5:5:90, vol/vol), stoppered, and incubated in a shaking water bath at 37°C for 2 hr. KOH (25 mM) in methanol (2 ml) and radioinert retinoic acid (5 ,ug) were added. Each sample was extracted twice with 2 ml of hexane to remove neutral lipids. The aqueous phase was acidified with 4 M HCI (0.17 ml), and retinoic acid was extracted with 2 ml of hexane. The hexane was evaporated under a stream of N2. Ethanol (0.2 ml) and diazomethane in diethyl ether (0.1 ml) were added to the residue. The solvents were evaporated; the residue was dissolved in column solvent and was applied to a normal-phase HPLC column. Methyl retinoate eluted in 27 ml with mobile phase 1 (toluene/hexane; 45:55, vol/vol); methyl 13-cis-retinoate eluted in 19 ml. Methyl retinoate was reapplied to the normal-phase HPLC column and was eluted with mobile phase 2 (methyl tert-butyl ether/hexane; 1:99, vol/vol) in 15 ml; methyl 13-cis-retinoate eluted in 11 ml; retinol, methyl 4-oxoretinoate, and methyl 5,6-epoxyretinoate eluted in greater than 25 ml.
[3H]Retinoic acid was quantified by measuring the radioactivity recovered in the fractions comigrating with radioinert methyl retinoate. Data were corrected for recovery by using a standard curve relating the peak height of radioinert methyl retinoate to the amount of retinoid.
Quantification of Laminin. Sixteen hours after cells were plated (3000/cm2), the medium was changed, and dibutyryl cAMP (1 mM, Sigma) was added, as was either retinoid or vehicle alone (day 1). The medium and dibutyryl cAMP were replenished daily for a total of 4 days. The amount of laminin in the medium at the end of day 4 was measured by an enzyme-linked immunoadsorbent assay (ELISA) modified from the procedure of Rennard et al. (22) . Briefly, 1:100 dilutions of medium aliquots or known amounts of purified laminin (standard curve) were incubated with rabbit antiserum to mouse laminin (E-Y Laboratories, San Mateo, CA) at 40C for 16 hr. The samples were transferred to laminin-coated (100 ng/well) Nunc microtest plates. After 30 min at 250C, the plates were washed, and a horseradish peroxidase-IgG conjugate was added to each well. After 90 min of incubation, unbound enzyme-IgG complexes were washed out, and o-phenylenediamine was added as substrate. The reaction was quenched after 30 min with 2 M sulfuric acid. Absorbance at 492 nm was read with a Titertek Multiscanner. Dose-response data were analyzed by computer, using a statistical method for fitting sigmoidal dose-response curves (23) . RESULTS Dose-Response Curves. Complete dose-response curves quantifying the effectiveness of retinoic acid and retinol were obtained with an ELISA for laminin, a marker of F9 cell differentiation (15, 24) . A half-maximum response was produced by either 1.3 nM retinoic acid or 226 nM retinol (Fig.  1A) . Retinoic acid (30-50 nM) and retinol (3-5 ,uM) produced equivalent maximum responses, which resulted in laminin concentrations of S ,ug/ml, 10-fold greater than in control medium. Maximum laminin concentrations at the end of day 4 required 48 hr of continuous exposure to retinoic acid (on days 1 and 2). Exposure for 24 hr (day 1 only) to the same concentration of retinoic acid (30 nM) achieved only 80% of the maximum, whereas 12 hr of exposure (on the first 12 hr of day 1) achieved only 39% of the maximum. For retinol (3 ,uM) , a maximum response required 72 hr of continuous exposure. Exposure for 24 hr achieved only 60% of the maximum laminin production. Ketoconazole, in the absence of retinoic acid, had no effect on laminin production, but (Fig. 2) . Retinyl esters, found exclusively in the cells, accumulated to an apparent steady-state concentration of 17 pmol per 106 cells by 10 hr. The metabolites of retinol present at 2, 4, 10, and 24 hr were qualitatively similar. HPLC profiles obtained at 24 hr (Fig. 5) were representative. After 24 hr, 68% of the retinoids in the cells was retinol. The major metabolite in the cells comigrated with retinyl palmitate (17% ofthe total). The remaining metabolites, 14% of the total after correcting for the amount observed in the control, were polar metabolites (fractions 39-53; Fig. 5 ). In the medium, 35% of the retinoids was retinol. Three groups ofpolar metabolites were observed in the medium (fractions 2-10, 39-45, and 46-53; Fig. 5 Fig. 3 (retinoic acid) Fig. 3 ; 7, retinol; 8, methyl all-trans-retinoate; 9, retinyl palmitate. Retinoids were quantified by reversed-phase HPLC using a linear gradient of methanol/water (45:55) to methanol, containing 10 mM ammonium acetate, over a 45-min period at a flow rate of 3 ml/min. Fractions were 2 ml each.
formation of the polar materials in the control was dependent upon the length of incubation and was not caused by the analytical methods because the peaks were not observed after 2 hr of incubation. No peak that was greater than the peaks in the controls was detected migrating with retinoic acid in cells or medium. Treating the predominant medium peak (fractions 39-45) with 8-glucuronidase (19) did not affect its elution position from HPLC-i.e., did not release retinoic acid.
The limit of detection was no lower than 1 pmol with the low specific activity retinol and with the methods used to examine the spectrum of retinol metabolites. An experimental approach with greater sensitivity was applied to determine whether F9 cells produced small amounts of retinoic acid.
The procedure relied upon [3H]retinol of 23-fold higher specific activity and methylation of the extract, followed by sequential analysis on two normal-phase HPLC systems to reduce background and to ensure specificity. A radioactive peak migrating with authentic methyl retinoate was observed during the first HPLC analysis (Fig. 6A) ; its production was cell dependent (Fig. 6C) . Reanalysis on the second HPLC system (Fig. 6B) showed that the peak consisted of retinoic acid (33%) and an unidentified metabolite (66%). The rate of retinoic acid synthesis was determined with the data from the second HPLC column to be 54 fmol/2 hr per 107 cells. Radioactive material in the controls, which eluted with retinoic acid from the first HPLC column and would include the unidentified metabolite, was below the limit of detection (<2.5 fmol; <250 dpm). The unidentified metabolite did not elute with any known retinoid.
DISCUSSION
Fundamental to understanding the mechanisms of vitamin A action is elucidating which retinoids elicit specific responses. The complex array of retinol and retinoic acid metabolites produced in vivo, the influence of vitamin A status on their production, and the rapid rate of retinoic acid turnover (19, 26) indicate that obtaining such knowledge could be problematic. In this regard, tissue homogenates or tissue explants suffer the disadvantages of heterogeneous cell populations, the inability to relate appearance of metabolites with the expression of specific responses, or both. F9 EC cells are a homogeneous population of undifferentiated cells and retinoids are the only naturally occurring substances that promote their differentiation (13) (14) (15) (16) (17) . Thus, these cells afford a propitious model system in which to examine the relationship between metabolism and differentiation induced by vitamin A.
The extensive production of metabolites during differentiation of F9 cells may allow accumulation of an active metabolite(s), decrease the effectiveness of retinoic acid, or both. No metabolite was observed in the cells in greater abundance than was observed in the medium; no differences were noted between the cell and medium metabolites; and exposing cells to retinoic acid accelerated its metabolism. These observations indicate that retinoic acid metabolism most likely represents conversion into hydrophilic excretion products and is similar to its disposition in vivo (19, 26, 27) . Although the cellular concentration of retinoic acid decreased with time, retinoic acid remained the most abundant retinoid in the cells. Ketoconazole, which inhibited the appearance of polar metabolites and produced a 3-fold increase in the half-life of retinoic acid, yielded a corresponding 3-fold increase in the potency of retinoic acid. Our results are consistent with the conclusion that retinoic acid acts directly to induce differentiation and modulates its own activity by accelerating the rate of its degradation.
Retinol has been estimated to be inactive in F9 cells (14) , two orders ofmagnitude less active than retinoic acid (28) and approximately 10% as active as retinoic acid (29) . These various conclusions were based on qualitative assessments of plasminogen activator activity and limited data. For example, the highest estimate of activity was based on the assessment of a single retinol concentration. In contrast, in this study complete dose-response curves were obtained by direct quantification of a product of differentiated cells (laminin), and retinol that was purified by normal-phase HPLC prior to assay was used. Commercially available retinol is impure, and retinol is transformed into polar materials on storage. The standard method of purification of retinol by reversedphase HPLC is much less effective (30) than normal-phase.
The most likely explanation for the lesser potency of retinol compared to that of retinoic acid is that its activity requires metabolism, perhaps to retinoic acid. Several ob-servations support the requirement of metabolic conversion for activity. Retinoic acid is produced from retinol by F9 cells, albeit at a low rate. The amount of cellular retinoic acid that commits cells to differentiate is also low. In medium containing 50 nM retinoic acid, the average amount ofcellular retinoic acid found was less than 0.1 pmol per 106 cells between 12 and 24 hr-a period in which the number of cells committed to differentiate doubled (Fig. 2) . At 1 gM retinol, which is virtually equipotent to 50 nM retinoic acid, cellular retinol levels increased rapidly and remained high (Fig. 2) , providing ample retinol to support continuous production of retinoic acid. Moreover, the induction of maximum F9 cell differentiation required considerably longer exposures to retinol (72 hr) than to retinoic acid (48 hr). This finding and the low rate of conversion of retinol into retinoic acid are consistent with a requirement for accumulation of sufficient product as a prerequisite to differentiation induced by retinol. The alternate explanation, that retinol and retinoic acid act independently, is not excluded by these data. Its demonstration, however, would require an ability to quantify femtomole amounts of retinoic acid during F9 cell differentiation and an inhibitor of retinoic acid synthesis.
Our observation of retinoic acid as the sole retinoid in F9 cell nuclei after incubation of intact cells with retinoic acid complements the recent report that cellular retinoic acidbinding protein mediates specific uptake of retinoic acid by isolated F9 cell nuclei (31) . These data are consistent with and expand current concepts that alteration of gene expression is one mechanism of retinoid action (32) . It would now be interesting to determine why a need exists for 24 to 48 hr of exposure of cells to retinoic acid to effect a maximum response.
